These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8759180)

  • 1. Predicting the growth response to growth hormone in patients with intrauterine growth retardation.
    Frank GR; Cheung PT; Horn JA; Alfaro MP; Smith EP; Chernausek SD
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):679-85. PubMed ID: 8759180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: a randomized controlled study.
    Soliman AT; abdul Khadir MM
    J Trop Pediatr; 1996 Oct; 42(5):281-6. PubMed ID: 8936959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.
    Azcona C; Preece MA; Rose SJ; Fraser N; Rappaport R; Ranke MB; Savage MO
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):787-92. PubMed ID: 10619985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Wit JM; Wolff ED; de Jong MC; Donckerwolcke RA; Abbad NC; Bot A; Blum WF
    Lancet; 1991 Sep; 338(8767):585-90. PubMed ID: 1715501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?
    Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is testosterone and estrogen priming prior to clonidine useful in the evaluation of the growth hormone status of short peripubertal children?
    Molina S; Paoli M; Camacho N; Arata-Bellabarba G; Lanes R
    J Pediatr Endocrinol Metab; 2008 Mar; 21(3):257-66. PubMed ID: 18540253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature.
    Cotterill AM; Camacho-Hübner C; Duquesnoy P; Savage MO
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):719-24. PubMed ID: 9713560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological growth hormone secretion and response to growth hormone treatment in children with short stature and intrauterine growth retardation.
    Stanhope R; Ackland F; Hamill G; Clayton J; Jones J; Preece MA
    Acta Paediatr Scand Suppl; 1989; 349():47-52; discussion 53-4. PubMed ID: 2750531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth parameters, growth hormone (GH) response to clonidine and circulating insulin-like growth factor-I (IGF-I), free thyroxine (FT4) and cortisol concentrations in relation to glycaemic control in children with insulin-dependent diabetes mellitus.
    Soliman AT; Ahmed HI; Asfour MG
    J Trop Pediatr; 1996 Aug; 42(4):228-32. PubMed ID: 8816035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH.
    Kamp GA; Zwinderman AH; Van Doorn J; Hackeng W; Frölich M; Schönau E; Wit JM
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):315-25. PubMed ID: 12201823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous and provoked growth hormone (GH) secretion and insulin-like growth factor I (IGF-I) concentration in patients with beta thalassaemia and delayed growth.
    Soliman AT; elZalabany MM; Mazloum Y; Bedair SM; Ragab MS; Rogol AD; Ansari BM
    J Trop Pediatr; 1999 Dec; 45(6):327-37. PubMed ID: 10667001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: a pulse amplitude-modulated phenomenon.
    Loche S; Puggioni R; Fanni T; Cella SG; Müller EE; Pintor C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):426-30. PubMed ID: 2918053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.